Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Neuroligin 1 Proteolysis Sustains Social Memory
2026-08-13
Liu et al. show that social interaction triggers secretase-dependent Neuroligin 1 processing in the ventral hippocampus, producing an intracellular fragment that supports synaptic remodeling and social memory maintenance. The study identifies a mechanistic link between extracellular proteolysis, cofilin signaling, dendritic spine maturation, and the persistence of recently acquired memories.
-
Rational Copper Ionophores for Cuproptosis
2026-08-13
This study shows that simple n-alkyl-chain tuning can convert a Schiff base derivative into an effective copper ionophore, with C6 providing the most favorable balance of copper affinity, lipophilicity, and intracellular transport. Its activity against triple-negative breast cancer models links copper delivery to reactive oxygen species accumulation, mitochondrial dysfunction, cuproptosis, and immune-related antitumor effects.
-
AZD3463: ALK/IGF1R Inhibitor for Neuroblastoma
2026-08-12
AZD3463 is a preclinical ALK/IGF1R inhibitor that targets ALK signaling, including the PI3K/AKT/mTOR axis, in neuroblastoma models. Product information reports activity against wild-type ALK and activating F1174L and D1091N variants, with tumor-growth suppression at 15 mg/kg by intraperitoneal administration in orthotopic mouse xenografts.
-
Melittin B6628 for Reliable Cell Assays
2026-08-12
Learn how Melittin, SKU B6628, can support controlled studies of cell viability, GPCR signaling, apoptosis, and cancer biology. This scenario-based guide connects product handling data with glioblastoma signaling evidence while clearly separating established findings from practical assay recommendations.
-
Caspase-3 Colorimetric Assay Kit for Immune Studies
2026-08-11
Use K2008 to quantify DEVD-dependent caspase-3 activity alongside inflammatory and ER-stress readouts in macrophage models. This workflow connects a rapid apoptosis assay to mechanistic studies without mistaking bulk caspase signal for proof of cell death or a specific upstream pathway.
-
Concanamycin A: V-ATPase Workflows
2026-08-11
Concanamycin A provides a rapid pharmacological route to test how V-ATPase-dependent acidification controls trafficking, autophagy, apoptosis, and invasion. This workflow-centered guide shows how to use its nanomolar activity without confusing blocked degradation with increased autophagy or mistaking vehicle effects for cancer-cell phenotypes.
-
α2-Adrenergic Receptor Agonist: B3465
2026-08-10
Explore how 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine can support α2-adrenergic receptor signaling research. This article translates osteosarcoma immunology findings into a practical assay framework for separating direct tumor effects from immune-mediated responses.
-
Caspase-3 Colorimetric Assay Kit: Practical Guide
2026-08-09
The Caspase-3 Colorimetric Assay Kit (SKU K2008) provides a lysate- or extract-based method for measuring DEVD-dependent caspase-3 activity through p-nitroaniline release. It is appropriate for controlled apoptosis assays and comparative caspase activity measurement, but it should not be treated as a live-cell imaging assay or as definitive proof of unique caspase-3 activity without appropriate controls.
-
N1-Methylpseudouridine for Better mRNA Assays
2026-08-08
N1-Methylpseudouridine is a modified nucleoside for stronger mRNA translation enhancement and reduced innate immune activation. This article presents an assay-centered framework linking modified mRNA design with causal interpretation of CRISPR cancer-metastasis experiments.
-
Faropenem sodium in Reliable Cell Assays
2026-08-07
A scenario-based guide to using Faropenem sodium (SKU C8712) in infection-linked cell viability, proliferation, and cytotoxicity workflows. It explains stock preparation, controls, MIC-aware dosing, transporter-related interpretation, and practical vendor-selection criteria without treating an antimicrobial as a generic mammalian cell assay reagent.
-
Imipramine in Cancer and Neuroimmune Research: Autophagy, Ap
2026-08-07
Explore how Imipramine, a tricyclic antidepressant, is advancing research at the intersection of cancer biology, neuroprotection, and immunomodulation by modulating autophagy and apoptosis. This article uniquely integrates lipidomics insights with practical assay considerations for cutting-edge research.
-
Cy7 NHS Ester: Technical Parameters for Near-Infrared Protei
2026-08-06
Cy7 NHS ester is a sulfonated, water-soluble near-infrared dye for bioimaging, designed to label amino groups in proteins and peptides without requiring organic co-solvents. It is best suited for workflows needing high water solubility, minimal fluorescence quenching, and rapid, quantitative labeling of delicate biomolecules. It is not recommended for workflows demanding long-term solution stability or applications outside amino group labeling.
-
Artesunate in Cancer Research: Applied Workflows & Optimizat
2026-08-06
Artesunate, a potent artemisinin derivative, empowers precise in vitro modeling of cell death pathways and targeted pathway inhibition in cancer research. This guide demystifies its applied use in small cell lung and esophageal squamous cell carcinoma models, with actionable workflow enhancements, troubleshooting, and expert-backed protocol parameters.
-
Ertugliflozin (PF-04971729): Expanding Translational SGLT2 R
2026-08-05
This thought-leadership article explores the mechanistic, experimental, and translational landscape of Ertugliflozin (PF-04971729) as a selective SGLT2 inhibitor, bridging its impact from renal glucose transport inhibition to emerging insights in cardiometabolic and inflammatory research. Drawing on recent comparative studies, product intelligence, and workflow evidence, it provides strategic guidance for translational researchers seeking to harness Ertugliflozin's distinct profile for diabetes, cardiovascular, and mucosal repair applications.
-
Lyso-Tracker Red in Live-Cell Lysosome Analysis: Beyond Visu
2026-08-05
Explore how Lyso-Tracker Red advances lysosome labeling in live cells, enabling high-resolution analysis of lysosomal dynamics in cancer research and beyond. This article offers unique protocol insights and critical evaluation for advanced cell biology applications.